Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC.

B.E. Shaw, MBChB, Nigel H. Russell, MD, A. Pagliuca, MD, J. Apperley, MD, G. Cook, MD, S. Mackinnon, MD, J.A. Madrigal, MD, D. Marks, MD, G.J. Morgan, MD, K. Peggs, MD, M.N. Potter, MD, K. Towlson, MD, J.L. Byrne, MD

Blood (2007) 110 (11): 46.

https://doi.org/10.1182/blood.V110.11.46.46

Published: 2007

Journal Articles

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

B.E. Shaw, G.J. Mufti, S. Mackinnon, J. Cavenagh, K. Towlson, R. Pearce, A. Pagliuca, J. Apperley, C. Craddock, M. Kazmi, T. Littlewood, D. Milligan, D. Marks, Nigel H. Russell

Blood (2006) 108 (11): 3660.

https://doi.org/10.1182/blood.V108.11.3660.3660

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Blood (2005) 106 (11): 1141.

https://doi.org/10.1182/blood.V106.11.1141.1141

Published: 2005

Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon

Blood (2004) 104 (11): 807.

https://doi.org/10.1182/blood.V104.11.807.807

Published: 2004

Journal Articles

The Role of PET Scanning in Directing Immune Manipulations Following Reduced Intensity Transplants in Adults with Lymphoid Malignancies.

N. Cooper, MD, I. Avivi, MD, K. Peggs, MD, D. Hart, MD, K. Thomson, MD, A. Goldstone, MD, D. Linch, MD, P. Ell, MD, J. Bomanji, MD, S. Mackinnon, MD

Blood (2004) 104 (11): 2261.

https://doi.org/10.1182/blood.V104.11.2261.2261

Published: 2004

Journal Articles

Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions

T.N. Small, E.B. Papadopoulos, F. Boulad, P. Black, H. Castro-Malaspina, B.H. Childs, N. Collins, A. Gillio, D. George, A. Jakubowski, G. Heller, M. Fazzari, N. Kernan, S. MacKinnon, P. Szabolcs, J.W. Young, R.J. O’Reilly

Blood (1999) 93 (2): 467–480.

https://doi.org/10.1182/blood.V93.2.467

Published: 1999

Journal Articles

Specific human cellular immunity to bcr-abl oncogene-derived peptides

M Bocchia, T Korontsvit, Q Xu, S Mackinnon, SY Yang, A Sette, DA Scheinberg

Blood (1996) 87 (9): 3587–3592.

https://doi.org/10.1182/blood.V87.9.3587.bloodjournal8793587

Published: 1996

Journal Articles

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

S Mackinnon, EB Papadopoulos, MH Carabasi, L Reich, NH Collins, F Boulad, H Castro-Malaspina, BH Childs, AP Gillio, NA Kernan

Blood (1995) 86 (4): 1261–1268.

https://doi.org/10.1182/blood.V86.4.1261.bloodjournal8641261

Published: 1995

Journal Articles

Minimal residual disease is more common in patients who have mixed T- cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

S Mackinnon, L Barnett, G Heller, RJ O'Reilly

Blood (1994) 83 (11): 3409–3416.

https://doi.org/10.1182/blood.V83.11.3409.3409

Published: 1994

Journal Articles

Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA

S Mackinnon, L Barnett, JH Bourhis, P Black, G Heller, RJ O'Reilly

Blood (1992) 80 (12): 3235–3241.

https://doi.org/10.1182/blood.V80.12.3235.3235

Published: 1992

Journal Articles

Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia

S Mackinnon, JM Hows, JM Goldman

Blood (1990) 76 (10): 2037–2045.

https://doi.org/10.1182/blood.V76.10.2037.2037

Published: 1990

NARROW

A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC.

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

Allogeneic Stem Cell Transplantation Using a Reduced Intensity Conditioning (RIC) Regimen Has the Capacity To Produce Durable Remissions and Long Term Disease-Free Survival in Patients with High Risk Acute Myeloid Leukemia (AML).

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

The Role of PET Scanning in Directing Immune Manipulations Following Reduced Intensity Transplants in Adults with Lymphoid Malignancies.

Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions

Specific human cellular immunity to bcr-abl oncogene-derived peptides

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

Minimal residual disease is more common in patients who have mixed T- cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA

Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only